The persistent struggle against hay fever may soon see a significant shift with the emergence of effective treatments. A new line of immunotherapy is reviving an old approach, offering hope for those suffering from seasonal allergies.
Glenis Scadding, a prominent figure in the field, recalls a patient from decades ago whose debilitating hay fever kept him from even walking to the train station without wheezing. Through sublingual immunotherapy—a method that involves desensitizing the patient to allergens with drops placed under the tongue—Scadding was able to transform his life. Yet, she faced skepticism and criticism, which led her to pause her practice of this treatment.
Allergic rhinitis affects over 400 million individuals globally. This condition, marked by nasal inflammation triggered by airborne allergens, results in symptoms like sneezing, a runny nose, and itchy eyes. When these symptoms occur seasonally, particularly due to pollen, it is commonly referred to as hay fever. Beyond discomfort, hay fever can have severe long-term health implications, including an increased risk of respiratory infections and asthma.
In the UK alone, about one in four adults and one in eight children experience allergic rhinitis, leading to millions of doctor visits annually. Alarmingly, research indicates a rising prevalence of these allergies in regions like Europe, the US, and Australia, exacerbated by climate change.
Fortunately, allergists report that effective therapies for hay fever are becoming available. While most treatments focus on alleviating symptoms, allergen immunotherapy (AIT) stands out as a potential cure, retraining the immune system to respond less aggressively to specific allergens. Experts agree that many patients could benefit from these treatments, but access remains limited.
A Serious Health Concern
Despite the widespread impact of allergic rhinitis, many healthcare providers do not take it seriously. Stephen Durham, a clinical allergist, notes that general practitioners often suggest over-the-counter antihistamines instead of referring patients to specialists or considering long-term treatments like immunotherapy. He emphasizes that hay fever significantly affects daily activities, including work, sleep, and leisure.
Moreover, studies have shown that individuals with hay fever experience more sleep disturbances and fatigue, which can adversely affect children's educational performance. Unmanaged hay fever can also lead to chronic conditions such as upper airway disease and ear infections.
There’s a more significant concern as well: untreated hay fever can lead to asthma, which may be more severe in those who also suffer from allergies. As Barrie Cohen, a pediatric allergist, explains, inflammation in the upper airways can influence lower airway conditions through shared immune pathways.
Historical Perspectives and Innovations
Hay fever is not a modern issue. John Bostock, a physician in London, documented seasonal allergy symptoms as early as 1828. Immunotherapy techniques have been around since at least 1911, with the first double-blind trials occurring in the mid-20th century. While traditional allergy shots have been highly effective, they carry risks of severe allergic reactions, which have led to regulatory changes over the years.
In the 1980s, Scadding began pioneering sublingual immunotherapy, which involves placing allergen extracts under the tongue. Initial skepticism regarding its efficacy has since been overcome by clinical trials demonstrating its lower risk of anaphylaxis compared to injections. The World Health Organization recognized this method as a legitimate alternative, further promoting its use.
Patients must adhere to a consistent regimen, taking sublingual tablets daily for eight to sixteen weeks before pollen season to achieve optimal results. Studies show that starting treatment early can control symptoms in about 85% of patients.
Long-Term Benefits
Excitingly, research indicates that the benefits of sublingual immunotherapy can persist long after treatment has concluded. Clinical trials have shown symptom improvement lasting up to two years post-therapy. However, the range of allergies that sublingual treatments can address remains limited, prompting some allergists to recommend traditional shots for certain patients.
Regardless of the method, allergen immunotherapy has proven effective for many, providing significant reductions in both hay fever and asthma-related medication use. One study found that children with grass pollen allergies who underwent sublingual treatment were significantly less likely to develop asthma symptoms compared to those who did not receive treatment.
For individuals with existing asthma, allergen immunotherapy may not always be suitable, particularly if their condition is severe or uncontrolled. In such cases, biologic medications targeting specific immune pathways may be an option, though they come with a higher cost and do not offer the same long-term benefits as immunotherapy.
Managing Allergies Effectively
Cost and accessibility of treatments can be barriers for many patients. Allergists recommend using antihistamine and corticosteroid nasal sprays as the most effective first line of defense, emphasizing the importance of starting treatment before allergy season begins. Proper administration of these sprays is crucial for effectiveness.
Reducing exposure to allergens also plays a vital role. Strategies such as keeping windows closed, using air purifiers, and washing up upon returning home can help minimize symptoms. While hay fever can be debilitating, effective treatments are available, and understanding how to manage allergies properly can significantly enhance quality of life.
Source: Bbc News